All odd numbered posters will be presented on Friday, November 8, 2019, while even numbered posters will be presented on Saturday, November 9, 2019.
Posters will be on display from 7 a.m. - 8 p.m., with the presenting authors required to be at their posters during lunch (12:30 - 2 p.m. on Friday, Nov. 8, and 12:35 - 2:05 p.m. on Saturday, Nov. 9) and also during the poster reception (6:30 - 8p.m. on Friday, Nov. 8, and 7 - 8:30 p.m. on Saturday, Nov. 9).
|P831||Inclusion of people living with HIV in anti-PD(L)1 clinical trials: Results of an NCI-driven initiative to broaden eligibility in clinical trial development||Joshua E. Reuss, MD; Diana Stern, MD; Ramya Ramaswami; Kathryn Lurain, MD; Helen Chen, MD; Howard Streicher, MD; Ravie Kem, RPh, Pharm D, MPH; Richard F. Little, MD; Elad Sharon, MD, MPH;||Regulatory, Financial, and Access Considerations||Checkpoint blockade; Clinical trial|
|P832||Systematic literature review (SLR) of intravenously (IV) administered oncology therapies for which a subcutaneous (SC) formulation has also been developed||Brad Schenkel, MSc; Elise Wu; Ali McBride; Marília Hernani; Robin Wyn; Klaudia Kornalska;||Regulatory, Financial, and Access Considerations||Clinical study; Targeted therapy|